Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer

Conditions: Oral Cancer; Psychological Distress; Communication Aids for Disabled; Physiotherapy; Return to Work; Prehabilitation; Physical Symptom Distress; Motor Function; Rehabilitation; Quality of Life; Cost Effectiveness; Artifical Intelligence; Prediction Model; Case Management, APP(Application)

Interventions: Device: Prehabilitation application; Behavioral: Conventional physiotherapy; Behavioral: Scar management; Behavioral: AI-based physiotherapy

Sponsors: Taipei Veterans General Hospital, Taiwan; National Taiwan University Hospital; National Yang Ming Chiao Tung University Hospital

Recruiting

STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence

NEWARK, N.J. — OxyContin maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week’s end, as a massive legal settlement resolving thousands of lawsuits takes effect.

A federal judge on Tuesday delivered a criminal sentence to the company to resolve a Department of Justice probe — a last necessary step to clear the way for the settlement.

U.S. District Judge Madeline Cox Arleo made her decision after listening to hours of impact statements from people who lost loved ones or struggled with addiction themselves and requested she reject the negotiated sentence. While she didn’t go that far, she said she sympathized with people who bore the brunt of an epidemic linked to more than 900,000 deaths in the U.S. since 1999.

Continue to STAT+ to read the full story…